Panacea Biotec - Quaterly Results

30 May 2024 Evaluate
The company witnessed a 7.13% growth in the revenue at Rs. 803.70 millions for the quarter ended March 2024 as compared to Rs. 750.20 millions during the year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -13.70 millions as compared to Net Loss of Rs. -196.90 millions of corresponding quarter ended March 2023Operating Profit reported a sharp decline to 71.50 millions from 137.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 803.70 750.20 7.13 3596.00 2570.70 39.88 3596.00 2570.70 39.88
Other Income 163.90 102.70 59.59 249.10 344.30 -27.65 249.10 344.30 -27.65
PBIDT 71.50 137.00 -47.81 390.80 -281.90 -238.63 390.80 -281.90 -238.63
Interest 33.60 27.00 24.44 137.80 100.60 36.98 137.80 100.60 36.98
PBDT 37.90 110.00 -65.55 253.00 -382.50 -166.14 253.00 -382.50 -166.14
Depreciation 51.40 59.00 -12.88 210.90 245.00 -13.92 210.90 245.00 -13.92
PBT -13.50 51.00 -126.47 42.10 -627.50 -106.71 42.10 -627.50 -106.71
TAX 0.20 247.90 -99.92 6.60 247.90 -97.34 6.60 247.90 -97.34
Deferred Tax 0.20 247.90 -99.92 0.20 247.90 -99.92 0.20 247.90 -99.92
PAT -13.70 -196.90 -93.04 35.50 -875.40 -104.06 35.50 -875.40 -104.06
Equity 61.30 61.30 0.00 61.30 61.30 0.00 61.30 61.30 0.00
PBIDTM(%) 8.90 18.26 -51.28 10.87 -10.97 -199.10 10.87 -10.97 -199.10

Panacea Biotec Share Price

407.05 48.55 (13.54%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×